NEW YORK, Jan. 27, 2016 /PRNewswire/ -- Levi &
Korsinsky announces it has commenced an investigation of Enzon
Pharmaceuticals Inc. (NASDAQ: ENZN) concerning possible breaches of
Delaware law by the board of
directors of the company. To obtain additional information, go
to:
http://zlk.9nl.com/enzon-pharmaceuticals-enzn
or contact Joseph E. Levi, Esq.
either via email at jlevi@zlk.com or by telephone at (212)
363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in
New York, New Jersey, California, Connecticut, and Washington D.C. The firm's attorneys have
extensive expertise and experience representing investors in
securities litigation involving financial fraud, and have recovered
hundreds of millions of dollars for aggrieved shareholders.
Attorney advertising. Prior results do not guarantee similar
outcomes.
CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
Logo -
http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-levi--korsinsky-llp-announces-an-investigation-involving-possible-breaches-of-delaware-law-by-the-board-of-enzon-pharmaceuticals-inc-300210723.html
SOURCE Levi & Korsinsky, LLP